NYSE$ARMK

Aramark · Q1 2020 earnings

Q1 2020 earnings · · Investor relations

Briefing

Aramark's Q1 2020 financial performance largely materialized as expected and reflected the early actions of strategies to unlock the economic potential of the business.

Aramark reported a slight decrease in revenue, but organic revenue grew across all segments. Operating income and EPS decreased due to the prior year divestiture of the Healthcare Technologies business, but adjusted EPS remained unchanged. The company refinanced debt to strengthen its balance sheet.

  • Revenue decreased by 0.3%, but organic revenue increased by 1.6% with growth across all segments.
  • Operating Income decreased by 32%, while Adjusted Operating Income (AOI) decreased by 2%.
  • EPS decreased by 42% to $0.57, while Adjusted EPS remained unchanged at $0.62.
  • The company refinanced $900 million in debt, strengthening the balance sheet and improving financial flexibility.

Headline financials

Total Revenue

$4.25B

Previous: $4.27B-0.3%
EPS (adj)

$0.62

Previous: $0.63-1.6%
Free Cash Flow

$146M

Previous: $251M-41.9%
Net Income

$146M

Previous: $251M-41.9%
Operating Income

$254M

Previous: $373M-31.9%
Gross Profit

$254M

Previous: $373M-31.9%
Cash & Equivalents

$265M

Previous: $250M+5.9%
Total Assets

$14.3B

Previous: $13.7B+3.9%
Stock-Based Comp

$14.1M

Previous: $18.6M-24.0%

Revenue & EPS history

Aramark · Revenue · Quarterly

$4.25B

Q1 2020-0.3%vs Q1 2019
Beat estimate in 9 of 16 quarters(56%)
ActualEstimate

Forward guidance

As these strategies are implemented, the Company maintains its near-term financial performance outlook for Fiscal 2020.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q1 2020

Historical avgQ1 2020

+0.4%

Avg return

Earnings day

+1.5%

Avg return

5 days after

+3.4%

Avg return

30 days after

50%

27 / 54 earnings

Positive

+9.8%

Q2 2025

Best reaction

-9.0%

Q1 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q2 2026+1.1%+19.3%+22.4%
Q1 2026+5.6%+0.5%+3.1%
Q4 2025-5.2%-0.5%-0.7%
Q2 2025+9.8%+12.2%+16.2%
Q1 2025-2.1%-0.9%-7.6%
Q4 2024-2.8%-4.5%+4.2%
Q3 2024+1.8%+4.4%+13.0%
Q2 2024+0.8%+5.3%+3.4%
Q1 2024-1.8%+3.7%+7.5%
Q4 2023-5.2%-2.8%-3.3%
Q3 2023+9.0%+3.2%-3.4%
Q2 2023+7.2%+8.9%+19.0%
Q1 2023-9.0%-12.3%-18.3%
Q4 2022+4.2%+4.6%+7.4%
Q3 2022+3.1%+5.8%+4.7%
Q2 2022-4.4%-1.8%-1.5%
Q1 2022+3.3%-1.4%-4.3%
Q4 2021+0.3%-3.9%-12.2%
Q3 2021+0.5%+1.5%-4.7%
Q2 2021-3.5%+3.9%-0.3%
Q1 2021-0.7%-2.7%+12.5%
Q4 2020-3.3%+1.0%+7.9%
Q3 2020+1.8%+12.4%+37.7%
Q2 2020-7.0%+2.1%+10.5%
Q1 2020-1.9%-7.0%-23.3%
Q4 2019-0.4%-1.9%-0.5%
Q3 2019+8.0%+9.2%+20.4%
Q2 2019-2.6%+0.0%+12.4%
Q1 2019-1.4%-5.4%-11.4%
Q4 2018+2.4%+6.6%-5.4%
Q3 2018+5.1%+4.6%+6.0%
Q2 2018+1.1%+2.6%+6.1%
Q1 2018-4.8%-7.1%-6.8%
Q4 2017-7.0%-4.7%-2.0%
Q3 2017+0.7%-1.1%+1.3%
Q2 2017+2.9%+1.5%+9.1%
Q1 2017+6.0%+6.1%+8.5%
Q4 2016-8.7%-6.6%-0.6%
Q3 2016+5.5%+5.0%+4.3%
Q2 2016-3.2%
Q1 2016-0.6%
Q4 2015+9.2%
Q3 2015-0.1%
Q2 2015+1.6%
Q1 2015-3.4%
Q4 2012-1.5%
Q4 2014+4.3%
Q3 2013-0.3%
Q3 2014-0.3%
Q2 2013-2.0%
Q2 2014-2.0%
Q4 2013+3.4%
Q1 2014+3.4%
Q1 2013+3.4%
Q3 2012

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro